VHAQ-UN Company Profile and Key Details

VHAQ-UN has shown weak momentum, losing -5.73% over the past week and -12.3% over the past quarter, though year-to-date performance is down -12.3%.

Our AI price prediction model suggests that Viveon Health Acquisition Corp. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -13.75%, with price expected at $9.66 by November 23, 2023, within a range of $8.86 to $10.43

Viveon Health Acquisition Corp. (AMEX:VHAQ-UN) shares are down -12.3% year-to-date Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Viveon Health Acquisition Corp. trading at a premium to the broader market with a P/E of -251.12.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Viveon Health Acquisition Corp. (AMEX:VHAQ-UN) closed at $11.20 USD, gaining $0.20 (1.82%) from the previous close of $11.00. The stock is currently mid-range between its 52-week high and low $9.84 and $13.09. With a market capitalization of about $11.96 thousand, Viveon Health Acquisition Corp. is classified as a micro-cap and shows lower-than-market volatility (beta ~0.00). Key stats such as the average daily volume over the past year has been around 404.00 shares, volume is running light vs its 52-week average. Headquartered in Norcross, GA, Viveon Health Acquisition Corp. operates in the Financial Services sector and the Shell Companies industry. Viveon Health Acquisition Corp. does not have significant operations.

Viveon Health Acquisition Corp. trades at a P/E ratio of -251.12, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of 36.67 reflecting a rich premium to book value. The P/FCF stands at -37.92, also below market averages. Compared to sector medians, Viveon Health Acquisition Corp. P/S is trading at a discount to the sector, and the P/B is far higher than peers, underscoring the brand and earnings power premium investors assign to the stock.